Analyze the Characteristics of Susceptible Groups to Reduce the Pressure of Epidemic Prevention and Control

Yuan Tian; Jiawei Yang; Tianlong Cai; Yi Zhang; Ge lv

doi:10.62051/ijcsit.v2n2.36

Authors

Yuan Tian
Jiawei Yang
Tianlong Cai
Yi Zhang
Ge lv

DOI:

https://doi.org/10.62051/ijcsit.v2n2.36

Keywords:

Essential Are the Prevention and Control of Epidemic-Related Diseases, Health Surveillance, Public Comprehension of Epidemic Prevention, and the Allocation of Medical Resources

Abstract

This paper seeks to investigate the traits of those who are susceptible to epidemic transmission, and to devise effective tactics to alleviate the strain of epidemic prevention and control. By examining those who are vulnerable, the risk of epidemic transmission can be more precisely predicted and reacted to, thus enhancing the prevention and control effect. This paper first defines the definition and scope of susceptible people, and then makes an in-depth analysis of the characteristics of susceptible people, including physiological characteristics, social characteristics and psychological characteristics. On this basis, this paper puts forward targeted prevention and control strategies, including strengthening health monitoring, enhancing public awareness of epidemic prevention, and optimizing the allocation of medical resources. This paper also discusses the feasibility and the implementation difficulties of the prevention and control strategies, and puts forward the corresponding solutions. By delving deeply into the traits of vulnerable populations, more precise strategies and measures can be devised to avert and manage epidemics, thus diminishing the danger of contagion. To guarantee public health security and social equilibrium, it is essential to reduce the strain of epidemic prevention and control.

Downloads

Download data is not yet available.

References

Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J. (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine, 27(2), taaa021.

Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. The Lancet, 395(10223), 470-473.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., ... & Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727-733.

Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)[J]. Science, 2020, 368(6490): 489-493.

Lauer S A, Grantz K H, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application[J]. Annals of internal medicine, 2020, 172(9): 577-582.

Guan W J, Ni Z Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. New England journal of medicine, 2020, 382(18): 1708-1720.

Wu Z, McGoogan J M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. Jama, 2020, 323(13): 1239-1242.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The lancet, 2020, 395(10223): 497-506.

Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis[J]. International Journal of Infectious Diseases, 2020, 94: 91-95.

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. The lancet, 2020, 395(10223): 507-513.

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China[J]. Jama, 2020, 323(11): 1061-1069.

Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy[J]. Jama, 2020, 323(16): 1574-1581.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. The lancet, 2020,

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. The lancet, 2020, 395(10229): 1054-1062.

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J]. The lancet respiratory medicine, 2020, 8(5): 475-481.

Wang Y, Lu X, Li Y, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19[J]. American journal of respiratory and critical care medicine, 2020, 201(11): 1430-1434.

Zhang J J, Dong X, Cao Y Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China[J]. Allergy, 2020, 75(7): 1730-1741.

Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response[J]. Jama, 2020, 323(16): 1545-1546.

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China[J]. JAMA internal medicine, 2020, 180(7): 934-943

Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19[J]. Jama internal medicine, 2020, 180(8): 1081-1089.

Petrilli C M, Jones S A, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study[J]. Bmj, 2020, 369.

Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)[J]. JAMA cardiology, 2020, 5(7): 811-818.

Richardson S, Hirsch J S, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19.